Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module (OLD-NH-QC-DeMo)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03688542|
Recruitment Status : Active, not recruiting
First Posted : September 28, 2018
Last Update Posted : January 23, 2020
Older people residing in nursing homes (NH) are frequently polymedicated and often prescribed potentially inappropriate medications. Deprescribing has been proposed as a way to reduce the number of drugs they receive and their exposure to harmful treatments.
The objectives of this study are 1) To evaluate the effect of a deprescribing-specific interdisciplinary quality circle module on the use of potentially inappropriate medication in nursing-home residents. 2) To determine the effective strategies to reach and implement deprescribing consensus resulting of said quality circle module.
|Condition or disease||Intervention/treatment||Phase|
|Polypharmacy Inappropriate Prescribing||Other: Quality Circle Deprescribing Module||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||62 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module|
|Actual Study Start Date :||September 25, 2017|
|Estimated Primary Completion Date :||March 2020|
|Estimated Study Completion Date :||March 2020|
Nursing Homes allocated to the Intervention arm will enact the Quality Circle Deprescribing Module and create a local deprescribing consensus and implementation strategy.
Other: Quality Circle Deprescribing Module
The Quality Circle Deprescribing Module consist of a discussion bringing together nurses, physicians and responsible pharmacist to create a local deprescribing consensus for frequently used drug classes, as well as implementation strategies for the consensus..
No Intervention: Control
Nursing Homes allocated to the Control arm will not enact the intervention.
- Change in the proportion of PIMs use [ Time Frame: 12 months ]The primary outcome is the change at 12 months, relative to baseline, in the proportion of Potentially Inappropriate medication (PIMs) used in the NHs relative to their total drug consumption
- Difference in proportion of probably inappropriate galenic units and of possibly inappropriate galenic units [ Time Frame: 12 months ]
- Difference in proportion of probably inappropriate Defined Daily Doses (DDDs) and of possibly inappropriate DDDs: [ Time Frame: 12 months ]
- Number of hospital days [ Time Frame: 12 months ]The number of days spent in the hospital by residents in the nursing home
- Mortality rate [ Time Frame: 12 months ]The proportion of residents of the nursing home having died
- Number of falls per mean resident and per month [ Time Frame: 12 months ]
- Number of restraints measures per mean resident and per month [ Time Frame: 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03688542
|Centre de Pharamacie Communautaire|
|Lausanne, Vaud, Switzerland, 1011|
|Study Director:||Olivier Bugnon, Prof||University of Geneva|